InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: sox040713 post# 189346

Sunday, 07/09/2017 7:01:41 PM

Sunday, July 09, 2017 7:01:41 PM

Post# of 402957
Here's some partnership hype from Sept 2016... Partnership strategy came about in late 2015 (my correction) after the realization that B-ABSSSI wouldn't be affordable to proceed with a stock price under 2... Caused by Mako, Leo's up-listing fumble and ABSSSI's 30 million to proceed. Some of us thought partnership was the correct strategy for ABSSSI back in early 2015, but Leo was big-headed believing he was the next Regeneron and dismissed partnership chatter... All leverage was lost after the uplisting fumble (early 2015) which led to Mako's birth (8/15). Strategy shifted to cheaper trials in 2016...

http://www.ipharminc.com/press-release/2016/10/27/cellceutix-corporation-provides-business-update-and-timeline-of-upcoming-milestones

We are encouraged by the guidance and feedback that we have received from potential partners which are incorporated in our Phase 2a trial design."

We had previously been largely under the radar of Wall Street and institutional investors, but given our success to-date, we are now engaging in a much more aggressive outreach effort.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News